Nathan (Nick) B. Pliam, MD, PhD, an orthopedic surgeon and endocrine physiologist, is a Venture Partner with Bay City Capital, where he has focused on medical technology investments, including IDev Corporation, which was recently acquired by Abbott. He served as a director of Nevro Corporation. Dr. Pliam is also a Venture Partner at Decheng Capital, a Bay City Capital co-sponsored, Shanghai-based venture fund focused on life sciences investments relevant to the Chinese market. He is a co-founder of Ketai Medical Device Ltd, a China-based orthopedic implant company. He has founded, managed, and advised both biopharmaceutical and medical technology companies. He holds an MD from Dartmouth Medical School and a PhD from the University of California, San Francisco. Dr. Pliam completed his surgical training at UCSF and Stanford University. He completed his undergraduate degree in German literature at the University of California, Berkeley, and the Georg August Universite in Gattingen, Germany.